XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Equity Attributable to Breckenridge Prior to Acquisition
Common Stock
Additional Paid-in Capital
Accumulated (Deficit) Income
Accumulated Other Comprehensive Income (Loss)
Total
Balance at beginning of period at Dec. 31, 2022 $ 7,695 $ 238 $ 155,413 $ (112,469) $ (2,073) $ 48,804
Balance at beginning of period (in shares) at Dec. 31, 2022   23,812,329        
Increase (Decrease) in Stockholders' Equity            
Net Income (Loss) (976)     563   (413)
Unrealized (loss) income on foreign exchange rate translation         (6) (6)
Issuance of stock for Breckenridge acquisition (1,335) $ 12 2,008     685
Issuance of stock for Breckenridge acquisition (in shares)   1,188,235        
Excess of purchase price over net assets acquired     (10,565)     (10,565)
Breckenridge cash distributions prior to acquisition (3,055)         (3,055)
Deemed distribution of Breckenridge net assets not acquired (2,329)         (2,329)
Balance at end of period at Mar. 31, 2023   $ 250 146,856 (111,906) (2,079) 33,121
Balance at end of period (in shares) at Mar. 31, 2023   25,000,564        
Balance at beginning of period at Dec. 31, 2022 $ 7,695 $ 238 155,413 (112,469) (2,073) 48,804
Balance at beginning of period (in shares) at Dec. 31, 2022   23,812,329        
Increase (Decrease) in Stockholders' Equity            
Net Income (Loss)           (10,041)
Deemed distribution of Breckenridge net assets not acquired           (2,329)
Balance at end of period at Sep. 30, 2023   $ 308 156,678 (121,534) (2,048) 33,404
Balance at end of period (in shares) at Sep. 30, 2023   30,812,329        
Balance at beginning of period at Mar. 31, 2023   $ 250 146,856 (111,906) (2,079) 33,121
Balance at beginning of period (in shares) at Mar. 31, 2023   25,000,564        
Increase (Decrease) in Stockholders' Equity            
Net Income (Loss)       (4,430)   (4,430)
Unrealized (loss) income on foreign exchange rate translation         249 249
Balance at end of period at Jun. 30, 2023   $ 250 146,856 (116,336) (1,830) 28,940
Balance at end of period (in shares) at Jun. 30, 2023   25,000,564        
Increase (Decrease) in Stockholders' Equity            
Net Income (Loss)       (5,198)   (5,198)
Unrealized (loss) income on foreign exchange rate translation         (218) (218)
Issuance of stock for convertible note   $ 58 9,822     9,880
Issuance of stock for convertible note (in shares)   5,811,765        
Balance at end of period at Sep. 30, 2023   $ 308 156,678 (121,534) (2,048) 33,404
Balance at end of period (in shares) at Sep. 30, 2023   30,812,329        
Balance at beginning of period at Dec. 31, 2023   $ 308 156,678 (123,640) (1,912) $ 31,434
Balance at beginning of period (in shares) at Dec. 31, 2023   30,812,329       30,812,329
Increase (Decrease) in Stockholders' Equity            
Net Income (Loss)       5,846   $ 5,846
Unrealized (loss) income on foreign exchange rate translation         (160) (160)
Dividends declared       (9,860)   (9,860)
Balance at end of period at Mar. 31, 2024   $ 308 156,678 (127,654) (2,072) 27,260
Balance at end of period (in shares) at Mar. 31, 2024   30,812,329        
Balance at beginning of period at Dec. 31, 2023   $ 308 156,678 (123,640) (1,912) $ 31,434
Balance at beginning of period (in shares) at Dec. 31, 2023   30,812,329       30,812,329
Increase (Decrease) in Stockholders' Equity            
Net Income (Loss)           $ (3,317)
Balance at end of period at Sep. 30, 2024   $ 309 156,905 (136,817) (2,153) $ 18,244
Balance at end of period (in shares) at Sep. 30, 2024   30,906,777       30,906,777
Balance at beginning of period at Mar. 31, 2024   $ 308 156,678 (127,654) (2,072) $ 27,260
Balance at beginning of period (in shares) at Mar. 31, 2024   30,812,329        
Increase (Decrease) in Stockholders' Equity            
Net Income (Loss)       (3,546)   (3,546)
Unrealized (loss) income on foreign exchange rate translation         (110) (110)
Issuance of common stock as compensation   $ 1 258     259
Issuance of common stock as compensation (in shares)   133,850        
Shares exchanged for taxes on stock-based compensation     (76)     (76)
Shares exchanged for taxes on stock-based compensation (in shares)   (39,402)        
Balance at end of period at Jun. 30, 2024   $ 309 156,860 (131,200) (2,182) 23,787
Balance at end of period (in shares) at Jun. 30, 2024   30,906,777        
Increase (Decrease) in Stockholders' Equity            
Net Income (Loss)       (5,617)   (5,617)
Unrealized (loss) income on foreign exchange rate translation         29 29
Stock-based compensation expense     45     45
Balance at end of period at Sep. 30, 2024   $ 309 $ 156,905 $ (136,817) $ (2,153) $ 18,244
Balance at end of period (in shares) at Sep. 30, 2024   30,906,777       30,906,777